( ) -q-28- UNDATED (Correspondent Jeremy House) “for repaying profits.” The Supreme Court has rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. [CutID: <Cuts> SCOTUS-SHKRELI-house-q-MONam.mp3 Time: 28s Title: SCOTUS-SHKRELI-house-q-MONam Out-cue: for repaying profits] TAG: Correspondent Jeremy House reporting. —————————— VERBATIM: Shkreli appealed […]
Audio
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
( ) -q-28- UNDATED (Correspondent Jeremy House) “for repaying profits.”
The Supreme Court has rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug.
[CutID: <Cuts> SCOTUS-SHKRELI-house-q-MONam.mp3
Time: 28s
Title: SCOTUS-SHKRELI-house-q-MONam
Out-cue: for repaying profits]
TAG: Correspondent Jeremy House reporting.
——————————
VERBATIM: Shkreli appealed an order to return $64.6 million in profits he and his former company reaped after monopolizing the market for the medication and drastically increasing its price. His lawyers argued that money went to his company rather than him personally. Prosecutors, though, said the company had agreed in a settlement to pay $40 million, and because Shkreli masterminded the scheme, he should bear responsibility for repaying profits.